Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese MHLW Lists 99 Generics For NHI Pricing And Coverage

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Japan's Ministry of Health, Labor and Welfare Nov. 7 listed 99 generic drugs made from 35 composites for National Health Insurance price listing and coverage, according to an official of the ministry's Insurance Bureau Nov. 13

You may also be interested in...



Japan’s 2007 Generic Sales Rise 9 Percent To ¥425 Billion

TOKYO - Fiscal 2007 generic drug sales of Japan Generic Medicines Association's member firms grew 9 percent over the preceding year to ¥425.8 billion ($4.4 billion), the association reported Dec. 3

Japan’s 2007 Generic Sales Rise 9 Percent To ¥425 Billion

TOKYO - Fiscal 2007 generic drug sales of Japan Generic Medicines Association's member firms grew 9 percent over the preceding year to ¥425.8 billion ($4.4 billion), the association reported Dec. 3

Japan To Introduce New Quality Verification System For Generic Drugs

In an effort to reduce safety concerns about generic drugs and increase generic usage, Japan's Ministry of Health, Labor and Welfare will introduce a third-party verification system, in addition to the ministry's approval review. The new system will verify efficacy, and confirm that generics use the same active ingredients as brand products and contain no impure substances. MHLW has established a study group under the National Institute of Health Science to spearhead the system's implementation; the group's first meeting took place July 10. (Click here for more - Japanese language

UsernamePublicRestriction

Register

OM013057

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel